The Valley Desk

NCT02211131 · Interventional trial

Efficacy and Safety of Talimogene Laherparepvec Neoadjuvant Treatment Plus Surgery Versus Surgery Alone for Melanoma

Overall registry status Completed

Phase 2

Conditions Completely Resectable Stage IIIB, IIIC, or IVM1a Melanoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov